02 Grade comparison

Pure urolithin A or an extract: choosing a grade

Technical document 02 · Reviewed 2026-11-19 · Urolithin A

On this page
  1. A grade is a definition, not a number
  2. Pure, granulated, diluted or extract
  3. The content conversion
  4. What the powder does on the line
  5. What changes in the capsule or tablet
  6. What the panel can declare
  7. Clauses that make the grade testable

The catalog grade is a single substance: urolithin A powder at 98.0–102.0% by HPLC, milled to 40 mesh. The alternative on the market is an extract — either standardized to urolithin A or standardized to pomegranate ellagitannins, which are not urolithin A. The two differ in the mass needed per dose, the label declaration and the regulatory file, so the choice follows the dosage form and the destination market, not the word “natural”.

In one line

A grade is a definition of the powder, not a marketing tier: the assay, the carrier and the source decide the dose and the label.

A grade is a definition, not a number

A grade name hides three decisions: the source, the assay and the physical presentation. A 98% figure can describe a purified single substance, a purified extract or a blend assayed on a different basis. The figure narrows the field; it does not say which of the three is in the drum. Two suppliers can both quote “98% urolithin A” and be describing materials with different impurity profiles, different carriers and different regulatory histories.

The catalog grade resolves the first two decisions. It is a single substance, not a plant extract, and the assay window is the specification on the product page. The physical variants — granulated on request, dilution on request — change the powder, not the molecule, but they change the fill weight and the label.

Pure, granulated, diluted or extract

Urolithin A grades · what changes in the drum
GradeWhat it isUrolithin A contentLabel declaration
Pure powderSingle substance, 40 mesh98.0–102.0% by HPLCUrolithin A
Granulated pureAgglomerated pure powderSame assay, stated on the COAUrolithin A; granulation aid if used
DilutionPure powder on a declared carrierAssay × dilution factorUrolithin A and the carrier
Extract standardized to urolithin APlant-derived material purified to a stated figureStated %; requires its own methodExtract name and urolithin A %
Pomegranate extractEllagitannin extract, usually standardized to punicalaginsNot the marker; often low or unmeasuredPomegranate extract and its marker

The extract rows are different purchases, not variants of the catalog grade. A pomegranate extract standardized to punicalagins is a distinct ingredient, but it is not a measured dose of urolithin A; the pure versus extract page takes that comparison apart.

The content conversion

The arithmetic is the same for every grade: mass × assay = urolithin A. A 100 mg portion of a 99% powder carries 99 mg. A 500 mg portion of a 20% extract carries 100 mg, if the 20% is a measured urolithin A figure. The multiplication is only as good as the assay behind the percentage and the basis it is reported on.

The trap is the extract that is standardized to something else. Pomegranate extracts are commonly standardized to punicalagins or ellagic acid, both ellagitannins. Those are not urolithin A, and no multiplication turns a punicalagin figure into a urolithin A dose. The gut microbiota converts ellagitannins into urolithins, but that conversion is not a 1:1 arithmetic step and cannot be used to declare a urolithin A amount in a supplement panel. If the label promises urolithin A, the material has to be assayed for urolithin A.

What the powder does on the line

The pure grade is a 40 mesh powder, off-white to yellow, free-flowing, sparingly soluble in water. Granulation changes flow and density without changing the assay; it suits a tablet press or sachet line that struggles with a fine powder. Dilution lowers the assay and adds a carrier, which must be named on the label and in the specification. Neither step improves the molecule; each solves a handling problem.

An extract brings the physical character of its source. It may be finer, more hygroscopic, darker or more variable in taste, and it usually carries a carrier from spray-drying. Those are not defects, but they change the fill weight, the flow, the dispersion and the stability of the finished product. A formulator who switches from pure powder to an extract is reformulating, not just re-sourcing.

What changes in the capsule or tablet

In a capsule, the fill weight is the constraint. A pure grade at 99% delivers almost its own mass as urolithin A; an extract at 20% needs five times the powder for the same amount, which may not fit the capsule or may push out another ingredient. The label dose should set the fill weight, not the other way round.

Tablets add flow, density and compression. A granulated pure grade can run where a fine powder would not; an extract with a carrier may compress differently. In a stick pack or a drink mix, dispersion, colour and taste outweigh the last decimal of assay. A dilution can distribute a small dose evenly through a large sachet, but the carrier becomes part of the formula and the label.

The dose is a separate decision: the specification describes the material, not a daily intake. Whatever the dose, the mass of powder on the label has to match the assay of the lot used.

What the panel can declare

In the EU, the ingredient list names the source as it appears in the applicable rule. “Urolithin A” and “pomegranate extract” are different declarations, and a pomegranate extract cannot be presented as a measured amount of urolithin A. If the substance is a novel food, the authorised name and conditions, where they exist, decide the wording; the compliance page maps that by market.

In the US, the Supplement Facts panel declares urolithin A in milligrams, while the ingredient list names the extract or powder and its standardization. A panel that declares urolithin A from a punicalagin-standardized extract is declaring a substance the material does not contain at that level. In both markets the test is the same: is the panel number the amount of the substance named in the ingredient list?

Clauses that make the grade testable

  • “Urolithin A, 98.0–102.0% by HPLC, external standard, basis stated.”
  • “Identification by HPLC retention and NMR; loss on drying ≤1.0%; methanol ≤3,000 ppm.”
  • “Pb ≤1 · As ≤1 · Cd ≤1 · Hg ≤0.1 mg/kg; ≥95% through 40 mesh.”
  • “No carrier” for the pure grade; for a dilution, the carrier, the dilution factor and the assay basis.
  • For an extract, the plant source, the marker or markers, the urolithin A figure and its method.

A specification that names only “urolithin A 98%” leaves the source, the carrier and the basis open. Those three decide what the certificate means and what the label can print. A switch of grade is a revalidation: fill weight, flow, stability and label move, and the new lot needs its own certificate.

The parameters behind these clauses are on the COA page; the identity tests are on the identity page; the pack and lead time are on the MOQ page. The assay itself is described in the HPLC method note.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation